You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,144,609


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,144,609 protect, and when does it expire?

Patent 9,144,609 protects PROLENSA and is included in one NDA.

This patent has nineteen patent family members in thirteen countries.

Summary for Patent: 9,144,609
Title:Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
Abstract: An aqueous liquid preparation of the present invention containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or a hydrate thereof, an alkyl aryl polyether alcohol type polymer such as tyloxapol, or a polyethylene glycol fatty acid ester such as polyethylene glycol monostearate is stable. An embodiment of said liquid preparation does not include any preservative. Said aqueous liquid preparation in the form of an eye drop is useful for the treatment of blepharitis, conjunctivitis, scleritis, and postoperative inflammation. Also, the aqueous liquid preparation of the present invention in the form of a nasal drop is useful for the treatment of allergic rhinitis and inflammatory rhinitis (e.g. chronic rhinitis, hypertrophic rhinitis, nasal polyp, etc.).
Inventor(s): Sawa; Shirou (Hyogo, JP), Fujita; Shuhei (Hyogo, JP), Baklayan; George A. (Huntington Beach, CA), Padilla; Angeliqueo E. (Aliso Viejo, CA)
Assignee: SENJU PHARMACEUTICAL CO., LTD. (Osaka, JP)
Application Number:14/269,692
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,144,609
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,144,609: A Comprehensive Analysis

Introduction

United States Patent 9,144,609, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To delve into the specifics of this patent, it is crucial to understand the components and the broader patent landscape.

What is a Patent?

A patent is a form of intellectual property that gives the owner the right to exclude others from making, using, selling, and importing the invention for a certain period, usually 20 years from the filing date of the patent application[2].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO ensures that patents meet the criteria of novelty, non-obviousness, and usefulness before granting them[2].

Patent 9,144,609 Overview

To analyze the scope and claims of Patent 9,144,609, one must first identify the invention it describes. Here are the key steps:

Invention Description

The patent document begins with a detailed description of the invention, including its background, summary, and detailed description. This section provides context and explains how the invention works.

Claims

The claims section is the most critical part of the patent, as it defines the scope of the invention. Claims are statements that define the invention and distinguish it from prior art. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Analyzing the Claims

Independent Claims

Independent claims in Patent 9,144,609 would outline the broadest scope of the invention. For example, if the patent is for a new type of software algorithm, the independent claims might describe the algorithm's core functionality and its application.

Dependent Claims

Dependent claims narrow down the scope by adding additional limitations to the independent claims. These claims help to further define the invention and can be used to distinguish it from prior art.

Patent Scope and Protection

Patent Scope

The scope of a patent is determined by its claims. The broader the claims, the wider the scope of protection. However, broader claims are also more likely to be challenged for being too vague or overlapping with prior art.

Patent Protection

The protection offered by a patent is limited to the specific claims made. Any infringement must be evaluated against these claims to determine if the patent has been violated.

Obviousness-Type Double Patenting (ODP)

In cases where multiple patents are related, such as continuations or continuations-in-part, the issue of obviousness-type double patenting (ODP) can arise. ODP prevents the same inventor from obtaining multiple patents for the same invention or for obvious variations of the same invention. This was a key issue in the case of In re Cellect LLC, where the Federal Circuit affirmed the rejection of claims due to ODP[1].

Patent Term Adjustment (PTA)

Patent Term Adjustment (PTA) can extend the term of a patent if there are delays during the prosecution process. However, PTA does not affect the scope or claims of the patent but rather its duration. This is important because patents with PTA may expire on different dates than those without, even if they are part of the same patent family[1].

Searching and Analyzing Patents

Patent Search Tools

The USPTO provides several tools for searching patents, including the Patent Public Search tool, Global Dossier, and the Patent and Trademark Resource Centers (PTRCs). These tools help in identifying prior art and understanding the patent landscape[4].

Patent Claims Research Dataset

The USPTO also offers the Patent Claims Research Dataset, which contains detailed information on claims from U.S. patents granted between 1976 and 2014. This dataset can be used to analyze claim-level statistics and document-level statistics, providing insights into patent scope and trends[3].

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation. This is particularly relevant for small inventors and businesses that may not have the resources to engage in lengthy and expensive patent disputes[5].

Key Takeaways

  • Patent Claims: The claims section of a patent defines its scope and protection.
  • Patent Scope: The scope is determined by the breadth and specificity of the claims.
  • ODP: Obviousness-type double patenting prevents multiple patents for the same invention or obvious variations.
  • PTA: Patent Term Adjustment extends the patent term due to prosecution delays but does not affect the scope or claims.
  • Search Tools: USPTO provides various tools for searching and analyzing patents.
  • Legal Considerations: Small claims patent courts could simplify patent litigation.

FAQs

Q: What is the primary purpose of the claims section in a patent?

A: The primary purpose of the claims section is to define the scope of the invention and distinguish it from prior art.

Q: How does Obviousness-Type Double Patenting (ODP) affect patent claims?

A: ODP prevents the same inventor from obtaining multiple patents for the same invention or for obvious variations of the same invention.

Q: What is Patent Term Adjustment (PTA), and how does it affect a patent?

A: PTA extends the term of a patent due to delays during the prosecution process but does not affect the scope or claims of the patent.

Q: What tools does the USPTO provide for searching and analyzing patents?

A: The USPTO provides tools such as the Patent Public Search tool, Global Dossier, and the Patent and Trademark Resource Centers (PTRCs).

Q: Why is there a discussion about a small claims patent court?

A: A small claims patent court could simplify and reduce the costs associated with patent litigation, particularly for small inventors and businesses.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Claims Research Dataset, USPTO.
  4. Search for patents, USPTO.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,144,609

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch And Lomb PROLENSA bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 203168-001 Apr 5, 2013 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,144,609

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2003-012427Jan 21, 2003

International Family Members for US Patent 9,144,609

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1586316 ⤷  Subscribe C300494 Netherlands ⤷  Subscribe
European Patent Office 1586316 ⤷  Subscribe 11C0031 France ⤷  Subscribe
European Patent Office 1586316 ⤷  Subscribe 1190018-0 Sweden ⤷  Subscribe
European Patent Office 1586316 ⤷  Subscribe SPC/GB11/054 United Kingdom ⤷  Subscribe
European Patent Office 1586316 ⤷  Subscribe 122011100019 Germany ⤷  Subscribe
European Patent Office 1586316 ⤷  Subscribe 2011C/027 Belgium ⤷  Subscribe
European Patent Office 1586316 ⤷  Subscribe C 2011 004 Romania ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.